compound semaglutide lawsuit Novo Nordisk Files Patent Against Hims & Hers Over Compounded Products Compound versions of GLP-1 drugs

Patients should feel empowered to ask questions about their treatment plan, including why a particular GLP-1 medication was chosen, what specific monitoring is recommended, and when to seek urgent medical attention

These were originally investigated for diabetes, on the theory that GLP-1 increases insulin and thus decreases blood sugar

Understanding potential errors in patch application is essential for optimising therapeutic outcomes and minimising adverse effects

Whether your Cigna plan covers Wegovy (semaglutide) for chronic weight management depends on your specific plan design, your employers benefits decisions, and the formulary your plan uses